Literature DB >> 17644091

Peroxiredoxin-4 interacts with and regulates the thromboxane A(2) receptor.

Patrick Giguère1, Marie-Eve Turcotte, Emilie Hamelin, Audrey Parent, Jessy Brisson, Geneviève Laroche, Pascale Labrecque, Gilles Dupuis, Jean-Luc Parent.   

Abstract

We identified peroxiredoxin-4 (Prx-4) as a protein interacting with the beta isoform of the thromboxane A(2) receptor (TPbeta) by yeast two-hybrid analysis. Prx-4 co-immunoprecipitated constitutively with TPbeta in HEK293 cells. The second and third intracellular loops as well as the C-terminus of TPbeta interacted directly with Prx-4. Co-expression of Prx-4 caused a 60% decrease in cell surface expression of TPbeta. Prx-4 and TPbeta predominantly co-localized in the endoplasmic reticulum. Co-expression of Prx-4 in cells treated with H(2)O(2) targeted TPbeta for degradation. We show for the first time an interaction between a receptor involved in oxidative stress and Prx-4, an anti-oxidative enzyme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644091     DOI: 10.1016/j.febslet.2007.07.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Authors:  Anamika Basu; Hiya Banerjee; Heather Rojas; Shannalee R Martinez; Sourav Roy; Zhenyu Jia; Michael B Lilly; Marino De León; Carlos A Casiano
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

2.  Thromboxane and the thromboxane receptor in cardiovascular disease.

Authors:  Emer M Smyth
Journal:  Clin Lipidol       Date:  2010-04-01

3.  The effect of peroxiredoxin 4 on fly physiology is a complex interplay of antioxidant and signaling functions.

Authors:  Svetlana N Radyuk; Vladimir I Klichko; Katarzyna Michalak; William C Orr
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

4.  Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface.

Authors:  Karishma Palande; Onno Roovers; Judith Gits; Carola Verwijmeren; Yoshihito Iuchi; Junichi Fujii; Benjamin G Neel; Robert Karisch; Jan Tavernier; Ivo P Touw
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

5.  Cord blood administration induces oligodendrocyte survival through alterations in gene expression.

Authors:  D D Rowe; C C Leonardo; A A Hall; M D Shahaduzzaman; L A Collier; A E Willing; K R Pennypacker
Journal:  Brain Res       Date:  2010-09-29       Impact factor: 3.252

6.  Characterization of endothelial thromboxane receptors in rabbit aorta.

Authors:  Sandra L Pfister
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-09-02       Impact factor: 3.072

7.  Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model.

Authors:  Atsunori Nabeshima; Sohsuke Yamada; Xin Guo; Akihide Tanimoto; Ke-Yong Wang; Shohei Shimajiri; Satoshi Kimura; Takashi Tasaki; Hirotsugu Noguchi; Shohei Kitada; Teruo Watanabe; Junichi Fujii; Kimitoshi Kohno; Yasuyuki Sasaguri
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

8.  Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.

Authors:  Sheila Donnelly; Colin M Stack; Sandra M O'Neill; Ahmed A Sayed; David L Williams; John P Dalton
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

Review 9.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

10.  Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.

Authors:  Stephen J Wilson; Claire C Cavanagh; Allison M Lesher; Alexander J Frey; Shane E Russell; Emer M Smyth
Journal:  J Lipid Res       Date:  2009-01-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.